Total revenue for the first half of fiscal year 2025 was $5.26 million, representing an increase of 13.2% from $4.65 million for the same period of the previous year. After accounting for rising exchange rates, total revenue increased by 14.5% in RMB base currency. Gross profit was $1.47 million for the first half of fiscal year 2025, compared to $1.65 million in the same period of the previous year. Gross margin was 27.9%, down from 35.5% in the first half of fiscal year 2024. By segment, mold production revenue reached $3.63 million with a cost of revenue of $2.70 million and a gross margin of 25.6%. In the same period last year, mold production revenue was $3.31 million with a cost of revenue of $2.19 million and a gross margin of 33.8%. Net loss was $1.36 million for the first half of fiscal year 2025, compared to $0.27 million for the same period of the previous year. As of June 30, 2025, cash and cash equivalents totaled $1.76 million, compared to $2.08 million as of December 31, 2024. Net cash used in operating activities was $0.23 million, compared to $0.66 million for the same period of the previous year. Net cash used in investing activities was $0.30 million, compared to $3.16 million in the same period last year. Net cash provided by financing activities was $0.19 million, compared to $4.15 million for the first half of fiscal year 2024. Research and development expenses were $0.41 million for the first half of fiscal year 2025, an increase of 42.1% from the same period last year. Selling expenses were $0.05 million, a decrease of 57.2% from $0.13 million for the same period of the previous year. General and administrative expenses were $1.00 million, a decrease of 33.7% from $1.51 million in the first half of fiscal year 2024.